Chemical compounds I

Details for Australian Patent Application No. 2005257707 (hide)

Owner AstraZeneca AB

Inventors Tucker, Howard

Agent Freehills

Pub. Number AU-B-2005257707

PCT Pub. Number WO2006/001751

Priority 0401657-2 24.06.04 SE

Filing date 20 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 26 March 2009

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/001751 Priority application(s): WO2006/001751

26 March 2009 Application Accepted

  Published as AU-B-2005257707

23 July 2009 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257708-Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor CCR5

2005257706-Imidazole variants as modulators of GABA receptor for the treatment of GI disorders